Talk about labs and where they are and do they exist keep coming up. Is having multiple labs even necessary considering the big picture?
From one of his emails about BG:
- Testing services continue as a revenue source. However, our future expansion plans are where the real revenue is. Testing is (and has alway been) just "step one". Analytical testing is our platform for valuable data collection, which in turn drives BGMT's business strategy.
I'd think more would be concerned with the medical device! Which he has already stated to be a 2015 vison:
- I mentioned a year ago about BGMT's plans to enter the mobile health and mobile health device market. This continues to be our next product evolution for the alternative care marketplace. We've identified the technology, and we've identified our knowledge sources (IP). It's a hot market, and a hot product. As I predicted, this is one of the biggest tech buzzes now. It will take about 12 months of development to complete, with a prototype available around roughly the 6 month period. That timer starts once we have the resources aboard that we need to embrace full-fledged R&D. Impressive board members and executive appointments are also pending as we move forward along this tract. Much is in alignment. You will see these as future PRs, bearing that all continues to go to plan.
Am I wrong in thinking this? Why would people complain about a company in its infant stages? Even if you're just trading and not investing, move on to a different stock if you aren't satisfied with what you're seeing. Wouldn't that be less painful and probably more profitable than complaining, in all places, a chat board?
Part of today's news:
“We are not here to generate a quick buck, but rather to introduce a get rich slowly plan. Our business model presents a great way to grow with medical cannabis opportunities on a strong and steady path. Our true partners are our buy-and-hold investors. While our upgraded reporting status may be beneficial for day traders, we want to be clear that we are holding to our long term commitments by serving the needs of our true shareholders through building business and by growing the company.”
From one of his emails about BG:
- Testing services continue as a revenue source. However, our future expansion plans are where the real revenue is. Testing is (and has alway been) just "step one". Analytical testing is our platform for valuable data collection, which in turn drives BGMT's business strategy.
I'd think more would be concerned with the medical device! Which he has already stated to be a 2015 vison:
- I mentioned a year ago about BGMT's plans to enter the mobile health and mobile health device market. This continues to be our next product evolution for the alternative care marketplace. We've identified the technology, and we've identified our knowledge sources (IP). It's a hot market, and a hot product. As I predicted, this is one of the biggest tech buzzes now. It will take about 12 months of development to complete, with a prototype available around roughly the 6 month period. That timer starts once we have the resources aboard that we need to embrace full-fledged R&D. Impressive board members and executive appointments are also pending as we move forward along this tract. Much is in alignment. You will see these as future PRs, bearing that all continues to go to plan.
Am I wrong in thinking this? Why would people complain about a company in its infant stages? Even if you're just trading and not investing, move on to a different stock if you aren't satisfied with what you're seeing. Wouldn't that be less painful and probably more profitable than complaining, in all places, a chat board?
Part of today's news:
“We are not here to generate a quick buck, but rather to introduce a get rich slowly plan. Our business model presents a great way to grow with medical cannabis opportunities on a strong and steady path. Our true partners are our buy-and-hold investors. While our upgraded reporting status may be beneficial for day traders, we want to be clear that we are holding to our long term commitments by serving the needs of our true shareholders through building business and by growing the company.”
